Macrogenics (MGNX) Other Accumulated Expenses (2013 - 2019)
Macrogenics (MGNX) posted quarterly Other Accumulated Expenses of $175000.0 for Q3 2019, little changed year-over-year from $175000.0 in Q3 2018, and little changed quarter-over-quarter from $175000.0 in Q2 2019.
Powered by 
Analysis
Macrogenics (MGNX) Other Accumulated Expenses (2013 - 2019) Analysis & Trends
Macrogenics (MGNX) has reported Other Accumulated Expenses for 6 consecutive years, with $175000.0 the latest figure, recorded in Q3 2019.
- In Q3 2019, Other Accumulated Expenses changed 0.0% year-over-year to $175000.0; the TTM figure through Sep 2019 stood at $175000.0 (changed 0.0% YoY), while the FY2018 annual figure was $175000.0, down 63.0% from the prior year.
- Other Accumulated Expenses steadied at $175000.0 in Q3 2019 per MGNX's latest filing, from $175000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.6 million in Q1 2015 and bottomed at $175000.0 in Q3 2017.
- Historically, Other Accumulated Expenses has averaged $570384.6 across 4 years, with a median of $175000.0 in 2017.
- Annual changes were most pronounced in 2015 — Other Accumulated Expenses surged 342.25% — and 2018, when it sank 63.0%.
- Macrogenics' Other Accumulated Expenses stood at $727000.0 in 2015, then sank by 34.94% to $473000.0 in 2017, then tumbled by 63.0% to $175000.0 in 2018, then changed by 0.0% to $175000.0 in 2019.
- Business Quant data shows MGNX's Other Accumulated Expenses at $175000.0 in Q3 2019, $175000.0 in Q2 2019, and $175000.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Macrogenics | 284.90 Mn | 171.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 175,000.00 |
| Jun 30, 2019 | 175,000.00 |
| Mar 31, 2019 | 175,000.00 |
| Dec 31, 2018 | 175,000.00 |
| Sep 30, 2018 | 175,000.00 |
| Jun 30, 2018 | 175,000.00 |
| Mar 31, 2018 | 175,000.00 |
| Dec 31, 2017 | 473,000.00 |
| Sep 30, 2017 | 175,000.00 |
| Dec 31, 2015 | 727,000.00 |
| Sep 30, 2015 | 1.61 Mn |
| Jun 30, 2015 | 1.61 Mn |
| Mar 31, 2015 | 1.61 Mn |
| Dec 31, 2014 | 1.61 Mn |
| Sep 30, 2014 | 363,000.00 |
| Jun 30, 2014 | 363,000.00 |
| Mar 31, 2014 | 362,920.00 |
| Dec 31, 2013 | 363,000.00 |